Page last updated: 2024-09-02

aluminum phthalocyanine and Hepatocellular Carcinoma

aluminum phthalocyanine has been researched along with Hepatocellular Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JY; Huang, X; Qin, YL1
Lü, FD1

Other Studies

2 other study(ies) available for aluminum phthalocyanine and Hepatocellular Carcinoma

ArticleYear
Conjugation of sulfonated aluminum phthalocyanine to doxorubicin can improve the efficacy of photodynamic cancer therapy.
    Anti-cancer drugs, 2012, Volume: 23, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Humans; Indoles; Leukemia, Basophilic, Acute; Liver Neoplasms; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Rats

2012
[Experimental study of the photokilling effect of a new photosensitizer, aluminum phthalocyanine, on human hepatoma cell line].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1991, Volume: 13, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Indoles; Light; Liver Neoplasms; Organometallic Compounds; Radiation-Sensitizing Agents; Tumor Cells, Cultured

1991